Literature DB >> 3544081

The cholinergic neurotransmitter system in human memory and dementia: a review.

M D Kopelman.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3544081     DOI： 10.1080/14640748608401614

Source DB:  PubMed          Journal:  Q J Exp Psychol A        ISSN： 0272-4987


× No keyword cloud information.
  37 in total

1.  Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study.

Authors:  Julie A Dumas; Brenna C McDonald; Andrew J Saykin; Thomas W McAllister; Mary L Hynes; John D West; Paul A Newhouse
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

2.  Cholinergic blockade under working memory demands encountered by increased rehearsal strategies: evidence from fMRI in healthy subjects.

Authors:  Bianca Voss; Renate Thienel; Martina Reske; Thilo Kellermann; Abigail J Sheldrick; Sarah Halfter; Katrin Radenbach; Nadim J Shah; Ute Habel; Tilo T J Kircher
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-10-18       Impact factor: 5.270

3.  Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes.

Authors:  Miriam Z Mintzer; Roland R Griffiths
Journal:  Cogn Affect Behav Neurosci       Date:  2007-06       Impact factor: 3.282

4.  Acetylcholine in the orbitofrontal cortex is necessary for the acquisition of a socially transmitted food preference.

Authors:  Robert S Ross; Jill McGaughy; Howard Eichenbaum
Journal:  Learn Mem       Date:  2005-05-16       Impact factor: 2.460

5.  Alzheimer-type dementia and verbal memory performances: influence of selegiline therapy.

Authors:  G Finali; M Piccirilli; C Oliani; G L Piccinin
Journal:  Ital J Neurol Sci       Date:  1992-03

6.  RU 41,656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers.

Authors:  A Patat; M J Klein; A Surjus; M Hucher; J Granier
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  The effects of scopolamine, lorazepam, and glycopyrrolate on classical conditioning of the human eyeblink response.

Authors:  M Bahro; B G Schreurs; T Sunderland; S E Molchan
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 8.  Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging.

Authors:  Paul Bentley; Jon Driver; Raymond J Dolan
Journal:  Prog Neurobiol       Date:  2011-06-17       Impact factor: 11.685

9.  Effects of acute doses of oxiracetam in the scopolamine model of human amnesia.

Authors:  L Preda; M Alberoni; S Bressi; C Cattaneo; J Parini; N Canal; M Franceschi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.

Authors:  R P Dennes; J C Barnes
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.